A Pfizer logo is shown at a research facility in the La Jolla neighborhood of San Diego, California, U.S., September 30, 2025. REUTERS/Mike Blake March 23 (Reuters) - U.S. drugmaker Pfizer and ...
When Lyme disease makes the news, it's typically not for positive reasons — but Pfizer is gearing up to seek regulatory approval for a new vaccine candidate, CNBC reported. In April 2020, Pfizer and ...
An experimental Lyme disease vaccine from Pfizer and Valneva didn’t conclusively succeed in a large study, raising questions about the shot’s prospects.While the shot was more than 70% effective at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results